(PRWEB) April 16, 2013
The US Drug Watchdog is trying to help all women who have developed severe medical complications, such as erosion after having what was supposed to be a minimally invasive surgical procedure involving a transvaginal mesh product. Just to be clear on the scope and potential size of transvaginal mesh failures, according to the New York Times, "In 2010, about 185,000 US women underwent procedures in which mesh was implanted vaginally to treat urinary incontinence." The US Drug Watchdog says, " A transvaginal mesh failure occurs when the mesh fails to bind to a woman's pelvic tissues. As a consequence of this, the body rejects the mesh that has been sewn into it. As a result, the transvaginal mesh may start to poke its way through the vaginal wall and protrude out of the vaginal tissue. This complication is more commonly referred to as erosion. Erosion may result in extreme pain, infection, bleeding, vaginal discharge, and no possibility for sexual intercourse." The US Drug Watchdog's national initiative is designed to assist any women in the US, who is a victim of a transvaginal mesh failure involving erosion, and the group offering to provide all women victims with the specific contacts of national caliber attorneys-who are all women, because the damages are so gender specific. For more information women, who are now victims of a transvaginal mesh failure are urged to call the US Drug Watchdog anytime at 866-714-6466.
The US Drug Watchdog is indicating symptoms of a transvaginal mesh implant failure may include:
The US Drug Watchdog says, "One of the biggest problems we have with respect to our failed medical device or recalled drug initiative work is the average US consumer never hears about a drug recall or failures involving medical devices like a transvaginal mesh failure. If you have a friend, or loved one who is a recipient of a transvaginal mesh product that has already failed, please have them call us at 866-714-6466, especially if the failure involves erosion, or a failed revision surgery. We want to make certain all women, who are transvaginal mesh failure victims get to the best possible attorneys, to ensure they get the best possible compensation for their ordeal, and we will do our absolute best to make certain all of the attorneys are women." http://USDrugWatchdog.Com
U.S. District Court for the Southern District of West Virginia Multidistrict litigation (MDL) consolidates all similar cases into one courtroom and will include the Defendants:
C.R. Bard, Inc., (MDL No. 2187);
American Medical Systems Inc., MDL No. 2325);
Boston Scientific Corp., (MDL No. 2326); and Johnson & Johnson's Ethicon, Inc. (MDL No. 2327)
Read the full story at http://www.prweb.com/releases/2013/4/prweb10618083.htm.
Copyright©2012 Vocus, Inc.
All rights reserved